Federated Hermes Inc. lowered its position in Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) by 46.5% in the 2nd quarter, Holdings Channel reports. The fund owned 3,217 shares of the biopharmaceutical company’s stock after selling 2,792 shares during the quarter. Federated Hermes Inc.’s holdings in Cara Therapeutics were worth $29,000 as of its most recent […]